Jonathan T. Ting

Jonathan T. Ting

Auto-generated profile, based on publicly available information

Jonathan T. Ting

Allen Institute, Brain Health, Seattle, 98109, WA, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2011 in Nature
Verified
Journal Article
Open access
PDF file
João PeçaJoão Peça
João Peça
CFCátia Feliciano
Cátia Feliciano
JTJonathan T. Ting
Jonathan T. Ting
WWWenting Wang
Wenting Wang
MWMichael F. Wells
Michael F. Wells
GFGuoping Feng
Guoping Feng
Autism spectrum disorders (ASDs) comprise a range of disorders that share a core of neurobehavioural deficits characterized by widespread abnormalities in social interactions, deficits in communication as well as restricted interests and repetitive behaviours. The neurological basis and circuitry mechanisms underlying these abnormal behaviours are poorly understood. SHANK3 is a postsynaptic protein, whose disruption at the genetic level is thought to be responsible for the development of 22q13 deletion syndrome (Phelan–McDermid syndrome) and other non-syndromic ASDs. Here we show that mice with Shank3 gene deletions exhibit self-injurious repetitive grooming and deficits in social interaction. Cellular, electrophysiological and biochemical analyses uncovered defects at striatal synapses and cortico-striatal circuits in Shank3 mutant mice. Our findings demonstrate a critical role for SHANK3 in the normal development of neuronal connectivity and establish causality between a disruption in the Shank3 gene and the genesis of autistic-like behaviours in mice.

1 July 2018 in Cell
Verified
Journal Article
Closed access
TDTanya L. Daigle
Tanya L. Daigle
LMLinda Madisen
Linda Madisen
THTravis A. Hage
Travis A. Hage
MVMatthew T. Valley
Matthew T. Valley
UKUlf Knoblich
Ulf Knoblich
HZHongkui Zeng
Hongkui Zeng

1 January 2014 in Neuron
Verified
Journal Article
Closed access
ZGZengcai V. Guo
Zengcai V. Guo
NLNuo Li
Nuo Li
DHDaniel Huber
Daniel Huber
EOEran Ophir
Eran Ophir
DGDiego Gutnisky
Diego Gutnisky
KSKarel Svoboda
Karel Svoboda

20 June 2014
Verified
Book Chapter
Closed access
PDF file
JTJonathan T. Ting
Jonathan T. Ting
TDTanya L. Daigle
Tanya L. Daigle
QCQian Chen
Qian Chen
GFGuoping Feng
Guoping Feng

7 August 2011 in Nature Methods
Verified
Journal Article
Open access
PDF file
SZShengli Zhao
Shengli Zhao
JTJonathan T Ting
Jonathan T Ting
HAHisham E Atallah
Hisham E Atallah
LQLi Qiu
Li Qiu
JTJie Tan
Jie Tan
GFGuoping Feng
Guoping Feng
A collection of functionally characterized BAC transgenic mouse lines in which the channelrhodopsin-2 H134R variant is specifically and stably expressed in GABAergic, cholinergic, serotonergic or parvalbumin-positive neurons is reported. Optogenetic methods have emerged as powerful tools for dissecting neural circuit connectivity, function and dysfunction. We used a bacterial artificial chromosome (BAC) transgenic strategy to express the H134R variant of channelrhodopsin-2, ChR2(H134R), under the control of cell type–specific promoter elements. We performed an extensive functional characterization of the newly established VGAT-ChR2(H134R)-EYFP, ChAT-ChR2(H134R)-EYFP, Tph2-ChR2(H134R)-EYFP and Pvalb(H134R)-ChR2-EYFP BAC transgenic mouse lines and demonstrate the utility of these lines for precisely controlling action-potential firing of GABAergic, cholinergic, serotonergic and parvalbumin-expressing neuron subsets using blue light. This resource of cell type–specific ChR2(H134R) mouse lines will facilitate the precise mapping of neuronal connectivity and the dissection of the neural basis of behavior.

17 June 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
NGNathan W. Gouwens
Nathan W. Gouwens
SSStaci A. Sorensen
Staci A. Sorensen
JBJim Berg
Jim Berg
CLChangkyu Lee
Changkyu Lee
TJTim Jarsky
Tim Jarsky
CKChristof Koch
Christof Koch